Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

In Vitro Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 – 2025

Table of Content

1. Preface
     1.1. Report Scope and Market Segmentation
     1.2. Research Highlights

2. Assumptions and Research Methodology
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary

4. Market Overview
     4.1. Product Overview
     4.2. Key Industry Developments
     4.3. Global In Vitro Diagnostics Market Size (US$ Mn) Forecast
     4.4. Market Opportunity Map
     4.5. Porter’s Analysis 
     4.6. Global In Vitro Diagnostics Market Outlook
     4.7. Key Mergers and Acquisition
     4.8. Key Success Factor for Top 3 Players
     4.9. Regulatory Scenario
     4.10. Technology Assessment

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunity Analysis
     5.5. Opportunities

6. Global In Vitro Diagnostics Market Analysis By Technology Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global In Vitro Diagnostic Market Value Share Analysis, by Technology Type
     6.4. Global In Vitro Diagnostic Market Forecast, by Technology Type
            6.4.1. Point of Care
            6.4.2. Molecular Diagnostics
                     6.4.2.1. Polymerase Chain Reaction (PCR)
                     6.4.2.2. Isothermal Nucleic Acid Amplification Technology
                     6.4.2.3. Microarray
                     6.4.2.4. Hybridization
                     6.4.2.5. DNA Sequencing and Next Generation Sequencing
                     6.4.2.6. Other MDx Technologies
            6.4.3. Immunoassays
                     6.4.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
                     6.4.3.2. Radioimmunoassay (RIA)
                     6.4.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
                     6.4.3.4. Rapid Tests
                     6.4.3.5. Other Immunoassay Techniques
            6.4.4. Clinical Chemistry
                     6.4.4.1. Basic Metabolite
                     6.4.4.2. Electrolyte Panel
                     6.4.4.3. Liver Panel
                     6.4.4.4. Lipid Panel
                     6.4.4.5. Renal Panel
                     6.4.4.6. Thyroid Function
                     6.4.4.7. Specialty Chemical Tests
            6.4.5. Whole Blood Glucose Monitoring
            6.4.6. Hematology
            6.4.7. Clinical Microbiology
            6.4.8. Coagulation and Hemostasis
            6.4.9. Others
     6.5. Global In Vitro Diagnostics Market Analysis By Technology Type 
     6.6. Global In Vitro Diagnostics Market Attractiveness Analysis By Technology Type
     6.7. Key Trends

7. Global In Vitro Diagnostic Market Analysis, by Application
     7.1. Key Findings
     7.2. Introduction
     7.3. Global In Vitro Diagnostic Market Value Share Analysis, by Application
     7.4. Global In Vitro Diagnostic Market Forecast, by Application
            7.4.1. Drug testing
            7.4.2. Infectious Disease
            7.4.3. Oncology
            7.4.4. Metabolic Disease
            7.4.5. Autoimmune Disease
            7.4.6. Others
     7.5. Global In Vitro Diagnostics Market Analysis by Application
     7.6. Global In Vitro Diagnostic Market Attractiveness Analysis, by Application
     7.7. Key Trends

8. Global In Vitro Diagnostic Market Analysis, by End Users
     8.1. Key Findings
     8.2. Introduction
     8.3. Global In Vitro Diagnostic Market Value Share Analysis, by End Users
     8.4. Global In Vitro Diagnostic Market Forecast, by End Users
            8.4.1. Diagnostic Laboratories
            8.4.2. Hospitals
            8.4.3. Academic & Research Centers
            8.4.4. Home Care
            8.4.5. Others
     8.5. Global In Vitro Diagnostic Market Analysis, by End Users
     8.6. Global In Vitro Diagnostic Market Attractiveness Analysis, by End Users
     8.7. Key Trends

9. Global In Vitro Diagnostics Market Analysis, by Region
     9.1. Global In Vitro Diagnostic Market Scenario
     9.2. Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2016 and 2025 
     9.3. Global In Vitro Diagnostics Market Forecast, by Region
            9.3.1. North America
            9.3.2. Europe
            9.3.3. Asia Pacific
            9.3.4. Latin America
            9.3.5. Middle East & Africa
     9.4. Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2017–2025 

10. North America In Vitro Diagnostic Market Analysis
     10.1. Key Findings
     10.2. North America In Vitro Diagnostic Market Overview
     10.3. North America In Vitro Diagnostic Market Value Share Analysis, by Country
     10.4. North America In Vitro Diagnostic Market Forecast, by Country
            10.4.1. U.S.
            10.4.2. Canada
     10.5. North America In Vitro Diagnostic Market Value Share Analysis, by  technology Type
     10.6. North America In Vitro Diagnostic Market Forecast, by Technology Type
            10.6.1. Point of Care
            10.6.2. Molecular Diagnostics
                     10.6.2.1. Polymerase Chain Reaction (PCR)
                     10.6.2.2. Isothermal Nucleic Acid Amplification Technology
                     10.6.2.3. Microarray
                     10.6.2.4. Hybridization
                     10.6.2.5. DNA Sequencing and Next Generation Sequencing
                     10.6.2.6. Other MDx Technologies
            10.6.3. Immunoassays
                     10.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
                     10.6.3.2. Radioimmunoassay (RIA)
                     10.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
                     10.6.3.4. Rapid Tests
                     10.6.3.5. Other Immunoassay Techniques
            10.6.4. Clinical Chemistry
                     10.6.4.1. Basic Metabolite
                     10.6.4.2. Electrolyte Panel
                     10.6.4.3. Liver Panel
                     10.6.4.4. Lipid Panel
                     10.6.4.5. Renal Panel
                     10.6.4.6. Thyroid Function
                     10.6.4.7. Specialty Chemical Tests
            10.6.5. Whole Blood Glucose Monitoring
            10.6.6. Hematology
            10.6.7. Clinical Microbiology
            10.6.8. Coagulation and Hemostasis
            10.6.9. Others
     10.7. North America In Vitro Diagnostic Market Value Share Analysis, by Application
     10.8. North America In Vitro Diagnostic Market Forecast, by Application
            10.8.1. Drug testing
            10.8.2. Infectious Disease
            10.8.3. Oncology
            10.8.4. Metabolic Disease
            10.8.5. Autoimmune Disease
            10.8.6. Others
     10.9. North America In Vitro Diagnostic Market Value Share Analysis, by End User
     10.10. North America In Vitro Diagnostic Market Forecast, by End User
            10.10.1. Diagnostic Laboratories
            10.10.2. Hospitals
            10.10.3. Academic & Research Centers
            10.10.4. Home Care
            10.10.5. Others
     10.11. Market Trends

11. Europe In Vitro Diagnostic Market Analysis
     11.1. Key Findings
     11.2. Europe In Vitro Diagnostic Market Overview
     11.3. Europe In Vitro Diagnostic Market Value Share Analysis, by Country
     11.4. Europe In Vitro Diagnostic Market Forecast, by Country
            11.4.1. UK
            11.4.2. Spain
            11.4.3. Germany
            11.4.4. Italy
            11.4.5. France
            11.4.6. Rest of Europe
     11.5. Europe In Vitro Diagnostic Market Value Share Analysis, by Technology Type
     11.6. Europe In Vitro Diagnostic Market Forecast, by Technology Type
            11.6.1. Point of Care
            11.6.2. Molecular Diagnostics
                     11.6.2.1. Polymerase Chain Reaction (PCR)
                     11.6.2.2. Isothermal Nucleic Acid Amplification Technology
                     11.6.2.3. Microarray
                     11.6.2.4. Hybridization
                     11.6.2.5. DNA Sequencing and Next Generation Sequencing
                     11.6.2.6. Other MDx Technologies
            11.6.3. Immunoassays
                     11.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
                     11.6.3.2. Radioimmunoassay (RIA)
                     11.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
                     11.6.3.4. Rapid Tests
                     11.6.3.5. Other Immunoassay Techniques
            11.6.4. Clinical Chemistry
                     11.6.4.1. Basic Metabolite
                     11.6.4.2. Electrolyte Panel
                     11.6.4.3. Liver Panel
                     11.6.4.4. Lipid Panel
                     11.6.4.5. Renal Panel
                     11.6.4.6. Thyroid Function
                     11.6.4.7. Specialty Chemical Tests
            11.6.5. Whole Blood Glucose Monitoring
            11.6.6. Hematology
            11.6.7. Clinical Microbiology
            11.6.8. Coagulation and Hemostasis
            11.6.9. Others
     11.7. Europe In Vitro Diagnostic Market Value Share Analysis, by Application
     11.8. Europe In Vitro Diagnostic Market Forecast, by Application
            11.8.1. Drug testing
            11.8.2. Infectious Disease
            11.8.3. Oncology
            11.8.4. Metabolic Disease
            11.8.5. Autoimmune Disease
            11.8.6. Others
     11.9. Europe In Vitro Diagnostic Market Value Share Analysis, by End User
     11.10. Europe In Vitro Diagnostic Market Forecast, by End User
            11.10.1. Diagnostic Laboratories
            11.10.2. Hospitals
            11.10.3. Academic & Research Centers
            11.10.4. Home Care
            11.10.5. Others
     11.11. Market Trends

12. Asia Pacific In Vitro Diagnostic Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific In Vitro Diagnostic Market Overview
     12.3. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by Country
            12.3.1. India
            12.3.2. China
            12.3.3. Japan
            12.3.4. Australia and New Zealand
            12.3.5. Rest of Asia Pacific
     12.4. Asia Pacific In Vitro Diagnostic Market Forecast, by Country
     12.5. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by Technology Type
     12.6. Asia Pacific In Vitro Diagnostic Market Forecast, by Technology Type
            12.6.1. Point of Care
            12.6.2. Molecular Diagnostics
                     12.6.2.1. Polymerase Chain Reaction (PCR)
                     12.6.2.2. Isothermal Nucleic Acid Amplification Technology
                     12.6.2.3. Microarray
                     12.6.2.4. Hybridization
                     12.6.2.5. DNA Sequencing and Next Generation Sequencing
                     12.6.2.6. Other MDx Technologies
            12.6.3. Immunoassays
                     12.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
                     12.6.3.2. Radioimmunoassay (RIA)
                     12.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
                     12.6.3.4. Rapid Tests
                     12.6.3.5. Other Immunoassay Techniques
            12.6.4. Clinical Chemistry
                     12.6.4.1. Basic Metabolite
                     12.6.4.2. Electrolyte Panel
                     12.6.4.3. Liver Panel
                     12.6.4.4. Lipid Panel
                     12.6.4.5. Renal Panel
                     12.6.4.6. Thyroid Function
                     12.6.4.7. Specialty Chemical Tests
            12.6.5. Whole Blood Glucose Monitoring
            12.6.6. Hematology
            12.6.7. Clinical Microbiology
            12.6.8. Coagulation and Hemostasis
            12.6.9. Others
     12.7. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by Application
     12.8. Asia Pacific In Vitro Diagnostic Market Forecast, by Application
            12.8.1. Drug testing
            12.8.2. Infectious Disease
            12.8.3. Oncology
            12.8.4. Metabolic Disease
            12.8.5. Autoimmune Disease
            12.8.6. Others
     12.9. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by End User
     12.10. Asia Pacific In Vitro Diagnostic Market Forecast, by End User
            12.10.1. Diagnostic Laboratories
            12.10.2. Hospitals
            12.10.3. Academic & Research Centers
            12.10.4. Home Care
            12.10.5. Others
     12.11. Market Trends

13. Latin America In Vitro Diagnostic Market Analysis
     13.1. Key Findings
     13.2. Latin America In Vitro Diagnostic Market Overview
     13.3. Latin America In Vitro Diagnostic Market Value Share Analysis, by Country
            13.3.1. Brazil
            13.3.2. Mexico
            13.3.3. Rest of Latin America
     13.4. Latin America In Vitro Diagnostic Market Forecast, by Country
     13.5. Latin America In Vitro Diagnostic Market Value Share Analysis, by  technology Type
     13.6. Latin America In Vitro Diagnostic Market Forecast, by Technology Type
            13.6.1. Point of Care
            13.6.2. Molecular Diagnostics
                     13.6.2.1. Polymerase Chain Reaction (PCR)
                     13.6.2.2. Isothermal Nucleic Acid Amplification Technology
                     13.6.2.3. Microarray
                     13.6.2.4. Hybridization
                     13.6.2.5. DNA Sequencing and Next Generation Sequencing
                     13.6.2.6. Other MDx Technologies
            13.6.3. Immunoassays
                     13.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
                     13.6.3.2. Radioimmunoassay (RIA)
                     13.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
                     13.6.3.4. Rapid Tests
                     13.6.3.5. Other Immunoassay Techniques
            13.6.4. Clinical Chemistry
                     13.6.4.1. Basic Metabolite
                     13.6.4.2. Electrolyte Panel
                     13.6.4.3. Liver Panel
                     13.6.4.4. Lipid Panel
                     13.6.4.5. Renal Panel
                     13.6.4.6. Thyroid Function
                     13.6.4.7. Specialty Chemical Tests
            13.6.5. Whole Blood Glucose Monitoring
            13.6.6. Hematology
            13.6.7. Clinical Microbiology
            13.6.8. Coagulation and Hemostasis
            13.6.9. Others
     13.7. Latin America In Vitro Diagnostic Market Value Share Analysis, by Application
     13.8. Latin America In Vitro Diagnostic Market Forecast, by Application
            13.8.1. Drug testing
            13.8.2. Infectious Disease
            13.8.3. Oncology
            13.8.4. Metabolic Disease
            13.8.5. Autoimmune Disease
            13.8.6. Others
     13.9. Latin America In Vitro Diagnostic Market Value Share Analysis, by End User
     13.10. Latin America In Vitro Diagnostic Market Forecast, by End User
            13.10.1. Diagnostic Laboratories
            13.10.2. Hospitals
            13.10.3. Academic & Research Centers
            13.10.4. Home Care
            13.10.5. Others
     13.11. Market Trends

14. Middle East & Africa In Vitro Diagnostic Market Analysis
     14.1. Key Findings
     14.2. Middle East & Africa In Vitro Diagnostic Market Overview
     14.3. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by Country
            14.3.1. South Africa
            14.3.2. GCC
            14.3.3. Rest of Middle East & Africa
     14.4. Middle East & Africa In Vitro Diagnostic Market Forecast, by Country
     14.5. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by Technology Type
     14.6. Middle East & Africa In Vitro Diagnostic Market Forecast, by Technology Type
            14.6.1. Point of Care
            14.6.2. Molecular Diagnostics
                     14.6.2.1. Polymerase Chain Reaction (PCR)
                     14.6.2.2. Isothermal Nucleic Acid Amplification Technology
                     14.6.2.3. Microarray
                     14.6.2.4. Hybridization
                     14.6.2.5. DNA Sequencing and Next Generation Sequencing
                     14.6.2.6. Other MDx Technologies
            14.6.3. Immunoassays
                     14.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
                     14.6.3.2. Radioimmunoassay (RIA)
                     14.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
                     14.6.3.4. Rapid Tests
                     14.6.3.5. Other Immunoassay Techniques
            14.6.4. Clinical Chemistry
                     14.6.4.1. Basic Metabolite
                     14.6.4.2. Electrolyte Panel
                     14.6.4.3. Liver Panel
                     14.6.4.4. Lipid Panel
                     14.6.4.5. Renal Panel
                     14.6.4.6. Thyroid Function
                     14.6.4.7. Specialty Chemical Tests
            14.6.5. Whole Blood Glucose Monitoring
            14.6.6. Hematology
            14.6.7. Clinical Microbiology
            14.6.8. Coagulation and Hemostasis
            14.6.9. Others
     14.7. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by Application
     14.8. Middle East & Africa In Vitro Diagnostic Market Forecast, by Application
            14.8.1. Drug testing
            14.8.2. Infectious Disease
            14.8.3. Oncology
            14.8.4. Metabolic Disease
            14.8.5. Autoimmune Disease
            14.8.6. Others
     14.9. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by End User
     14.10. Middle East & Africa In Vitro Diagnostic Market Forecast, by End User
            14.10.1. Diagnostic Laboratories
            14.10.2. Hospitals
            14.10.3. Academic & Research Centers
            14.10.4. Home Care
            14.10.5. Others
     14.11. Market Trends

15. Company Profiles
     15.1. Competition Matrix 
     15.2. In Vitro Diagnostics Market Share Analysis, by Company, 2016 (Estimated)
            15.2.1. F. Hoffmann-La Roche Ltd.
                     15.2.1.1. Company Details
                     15.2.1.2. Business Overview
                     15.2.1.3. Financial Overview
                     15.2.1.4. Strategic Overview
                     15.2.1.5. SWOT Analysis
            15.2.2. Danaher
                     15.2.2.1. Company Details
                     15.2.2.2. Business Overview
                     15.2.2.3. Financial Overview
                     15.2.2.4. Strategic Overview
                     15.2.2.5. SWOT Analysis
            15.2.3. Siemens Healthineers 
                     15.2.3.1. Company Details
                     15.2.3.2. Business Overview
                     15.2.3.3. Strategic Overview
                     15.2.3.4. SWOT Analysis
            15.2.4. bioMérieux SA 
                     15.2.4.1. Company Details
                     15.2.4.2. Business Overview
                     15.2.4.3. Strategic Overview
                     15.2.4.4. SWOT Analysis
            15.2.5. Abbott 
                     15.2.5.1. Company Details
                     15.2.5.2. Business Overview
                     15.2.5.3. Strategic Overview
                     15.2.5.4. SWOT Analysis
            15.2.6. Diasorin
                     15.2.6.1.  Company Details
                     15.2.6.2. Business Overview
                     15.2.6.3. Strategic Overview
                     15.2.6.4. SWOT Analysis
            15.2.7.  Meridian Bioscience, Inc
                     15.2.7.1. Company Details
                     15.2.7.2. Business Overview
                     15.2.7.3. Strategic Overview
                     15.2.7.4. SWOT Analysis
            15.2.8. Ortho-Clinical Diagnostics, Inc 
                     15.2.8.1. Company Details
                     15.2.8.2. Business Overview
                     15.2.8.3. Strategic Overview
                     15.2.8.4. SWOT Analysis
            15.2.9. Thermo Fisher Scientific, Inc. 
                     15.2.9.1.  Company Details
                     15.2.9.2. Business Overview
                     15.2.9.3. Strategic Overview
                     15.2.9.4. SWOT Analysis
            15.2.10. Sysmex Corporation 
                     15.2.10.1. Company Details
                     15.2.10.2. Business Overview
                     15.2.10.3. Strategic Overview
                     15.2.10.4. SWOT Analysis
     15.4. Other Prominent Players

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote